Why are potassium and magnesium combined in cardiac glycoside toxicity rather than using potassium alone?

Magnesium ions are required to activate the $Na^+,K^+$-ATPase enzyme. Without a functioning enzyme, active transport of potassium ions into the cardiomyocyte is impossible, rendering potassium monotherapy ineffective.

In which types of arrhythmias is potassium magnesium aspartate indicated?

The drug is effective in tachyarrhythmias and extrasystoles, strictly under the condition that these rhythm disorders are caused by hypokalemia or hypomagnesemia.

Which diuretics require mandatory concurrent use of potassium supplements?

The primary risk of therapy with thiazide and thiazide-like diuretics is the development of hypokalemia, which mandates correction with potassium- and magnesium-containing preparations.

Home › Pharmacology › Potassium Magnesium Aspartate

Potassium Magnesium Aspartate

Tabulettae «Panangin»

For medical students2 min readUpdated 2026-10-10

Potassium magnesium aspartate is a combination drug from the group of agents acting on the cardiovascular system. It is used to replenish intracellular cation deficiency, normalize myocardial ion pump function, and eliminate dangerous electrolyte imbalances.

Pharmacological groupAgents acting on the cardiovascular system

Dosage formTablets (0.452 g potassium aspartate and 0.4 g magnesium aspartate)

Molecular targetCardiomyocyte $Na^+,K^+$-ATPase

Routes of administrationOral (per os) and intravenous

Mechanism of Action

The therapeutic effect of the drug is due to the synergistic action of two critical intracellular cations. Magnesium ions ($Mg^{2+}$) act as a cofactor and physiological activator of the enzyme $Na^+,K^+$-ATPase.

Activation of this ion pump is critically required for the active transport of potassium ions ($K^+$) across the cell membrane into cardiomyocytes. Thus, magnesium promotes the optimal uptake of potassium by myocardial tissues, restoring electrolyte balance and normalizing the excitability of the heart muscle.

Indications for Use

The drug is prescribed in situations where cardiovascular pathology is directly linked to electrolyte deficiency:

Cardiac arrhythmias: tachyarrhythmias and extrasystoles. Key condition for efficacy: the drug is justified only if the arrhythmia is triggered by hypokalemia or hypomagnesemia (a proven decrease in the concentration of these ions in blood plasma).
Cardiac glycoside toxicity: used in complex complication therapy to replenish $K^+$ and $Mg^{2+}$ deficiencies. It is prescribed alongside antidotes (such as unithiol) and agents that bind excess calcium (such as edetate disodium / Trilon B).
Prevention and treatment of diuretic-induced hypokalemia: a mandatory component of therapy when prescribing thiazide and thiazide-like diuretics, whose primary risk is renal potassium loss.

Side Effects

The use of the drug may be accompanied by adverse reactions affecting various body systems:

Cardiac: suppression of myocardial conduction, which can lead to the development of atrioventricular (AV) block.
Neurological: development of paresthesias (subjective sensations of numbness, tingling, or "pins and needles").
Gastrointestinal: dyspepsia (primarily with oral administration).

Dosage Forms and Prescription

In clinical practice, the drug is often prescribed under the trade name (Tabulettae «Panangin»). Each tablet contains potassium aspartate (0.452 g) and magnesium aspartate (0.4 g).

Standard oral dosing regimen: 1–2 tablets 3 times daily.

Prescription example: Rp.: Tab. «Panangin» N. 50 D.S. Take 1–2 tablets orally 3 times a day.

Mnemonic

Magnesium is the "key" that starts the motor ($Na^+,K^+$-ATPase) so potassium can "drive" inside the cardiomyocyte.

Frequently asked questions

Why are potassium and magnesium combined in cardiac glycoside toxicity rather than using potassium alone?: Magnesium ions are required to activate the $Na^+,K^+$-ATPase enzyme. Without a functioning enzyme, active transport of potassium ions into the cardiomyocyte is impossible, rendering potassium monotherapy ineffective.
In which types of arrhythmias is potassium magnesium aspartate indicated?: The drug is effective in tachyarrhythmias and extrasystoles, strictly under the condition that these rhythm disorders are caused by hypokalemia or hypomagnesemia.
Which diuretics require mandatory concurrent use of potassium supplements?: The primary risk of therapy with thiazide and thiazide-like diuretics is the development of hypokalemia, which mandates correction with potassium- and magnesium-containing preparations.

Go deeper

Mechanism of action of cardiac glycosides and pathogenesis of glycoside toxicity
Thiazide and thiazide-like diuretics: effects on electrolyte balance
Antidote therapy for cardiac glycoside poisoning (Unithiol, Edetate disodium)
Types of atrioventricular blocks and their pharmacological management (Atropine)
Polarizing solutions: composition, indications, and the role of potassium chloride